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Background: The aim of this study was to determine the effects of an elastic mandibular advancement (EMA) appliance on upper 
airway dimensions, most constricted area (MCA) of the airway, and snoring in a sample of obstructive sleep apnoea (OSA) 
patients of varying severity. 
Methods: Forty-seven male subjects were classified into two groups comprising12 controls and 35 suffering from OSA. The 
OSA group was further divided into three subgroups based on their apnoea-hypopnoea index (AHI). All subjects completed 
an Epworth questionnaire and an overnight home sleep test before (T1) and at the end of the study (T2). OSA subjects were 
provided with a custom-made EMA appliance. Cone beam computed tomographic images were obtained for each subject at 
T1 and T2. Airway parameters were measured and summarised by grouping. The differences in the measurements T1 – T2 were 
compared using repeated measures analysis of variance (rmANOVA) and p ≤ 0.05 was considered statistically significant. 
Results: The use of the EMA produced a statistically significant increase in the nasopharyngeal, oropharyngeal, MCA, and total 
airway volume. Although sleep apnoea patients reported a reduction in snoring time, particularly in moderate and severe OSA 
groups, the level of improvement was not statistically significant. Patients with moderate and severe OSA demonstrated significant 
decreases in their AHI and Epworth scores. 
Conclusion: EMA is effective in reducing OSA severity and changing airway dimensions in OSA patients, specifically in the 
moderate and severe cases.
(Aust Orthod J 2017; 33: 14-23)
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Introduction
Obstructive sleep apnoea (OSA) is a common medical 
condition that is associated with adverse health con-
sequences. It is characterised by repetitive, partial, or 
complete obstruction of the upper airway during sleep 
despite simultaneous respiratory efforts. OSA affects 
2% to 4% of middle-aged adults and up to 28% of 
the population older than 65 years.1-4 Patients with 
OSA suffer from snoring, nocturnal awakenings, ex-
cessive day-time sleepiness, memory lapses, difficulty 
in concentrating, depression, irritability, xerostomia, 
gasping for breath at night, and witnessed apnoeas. 
OSA has also been linked to several cardiovascular dis-
eases and hypertension.2,5-8
The key diagnostic tool used to describe the presence 
and severity of OSA is the apnoea-hypopnea index 
(AHI), which is usually derived from polysomnography 
or a portable monitoring device such as the home 
Watermark Medical™ Apnoea Risk Evaluation 
System (ARES™) home sleep test, and is calculated 
based on the total number of apnoea and hypopnea 
episodes per hour of sleep. The presence of OSA is 
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defined by an AHI of five or more events per hour 
in association with symptoms. The severity of OSA 
is judged by a composite of the severity of symptoms 
and the polysomnography/portable monitoring 
findings.7-10 
Craniofacial abnormalities including micrognathia, 
retrognathia, and narrowing of the upper airway have 
been reported to be associated with OSA.11 There is 
also strong evidence that morbid obesity, increased 
body mass index (BMI) calculated as weight divided 
by the square of height, large neck circumference, and 
greater waist-to-hip ratio are considered risk or even 
causal factors in OSA. Other suspected risk factors 
include genetics, smoking, menopause, alcohol use 
before sleep, and night-time nasal congestion.3,12-15 
Treatment options range from general measures 
such as weight loss, avoidance of sleep in the supine 
position, and nasal continuous positive airway pressure 
(CPAP) to the more invasive surgical approaches, or 
the use of oral appliances. Oral appliances could be 
considered a potentially useful option especially for 
patients with mild-to-moderate disease and patients 
who do not tolerate CPAP machines, who decline 
or are unsuccessfully treated by surgery.9,15-18 Oral 
appliances relieve airway collapse during sleep by 
holding the mandible in a more forward position 
and so modify the position of the tongue and the 
pharyngeal structures.16,18 The clinical effects of a 
mandibular advancement appliance on the severity of 
OSA, widening the most constricted area (MCA) of 
the airway and improving snoring remain uncertain 
and require further validation. The objectives of the 
present study were to evaluate the effects of using an 
elastic mandibular advancement (EMA) appliance on 
upper airway dimensions and the MCA of airway as 
well as on improving snoring symptoms in a group of 
sleep apnoea patients with varying OSA severity.
Materials and methods
Forty-seven subjects were recruited from the Indiana 
University School of Medicine Sleep Clinic and the 
Indiana University School of Dentistry. Inclusion 
criteria identified Caucasians, males whose age 
ranged from 27–65 years and who underwent 
polysomnography. All were diagnosed by a sleep 
medicine physician as having AHI > 5 for the OSA 
group and < 5 for the control group. The exclusion 
criteria identified subjects who had mandibular 
protrusion (Class III malocclusion), inadequate 
teeth for appliance retention, were unable to move 
the mandible forward, had major dental and/or 
periodontal disease or recent surgery, a history of 
temporo-mandibular disorders, a history of heart 
failure, significant medical or renal disease, pharyngeal 
and/or nasal disease, and subjects on medications that 
depress respiration. The study was approved by the 
Indiana University Institutional Review Board and 
written informed consent was obtained from each 
subject.
A sleep medicine physician examined and diagnosed 
the subjects as having or not having OSA. Patient 
neck size, height and weight were measured and body 
mass index (BMI) calculated. Subjective sleepiness 
was assessed by the Epworth Sleepiness Scale (ESS). 
Following instruction, all subjects were given the 
ARES™ (Watermark Medical®, FL, USA) home 
sleep test device to monitor their overnight sleep 
apnoea state. The Watermark device provided data 
regarding AHI, the respiratory disturbance index 
(RDI) and the percentage snoring time. A diary to 
record mandibular appliance wear was provided to 
the OSA patients to assess compliance, adverse effects, 
the level of discomfort and snoring (as indicated by 
sleeping partners).
The subjects were divided into four groups based on 
the severity of the disease according to their AHI level. 
Group 1 (N=12): control subjects with AHI <5, group 
2 (N=12): mild OSA subjects with AHI = >5 – <15, 
group 3 (N=12): moderate OSA subjects with AHI 
>15 – <30, and group 4 (N=11): severe OSA subjects 
with AHI = 30 or greater. Following an orthodontic 
examination and impressions, OSA subjects were 
provided with an EMA appliance comprised of 
two plastic trays custom moulded to the patient’s 
maxillary and mandibular arches to utilise the dental 
undercut areas for retention (Figure 1). Mandibular 
advancement was achieved by providing the patient 
with same size elastic straps (21 mm) to hold the 
mandible 4 mm in a forward direction while the same 
vertical opening was adjusted using bite planes. The 
forward position of the mandible was achieved in all 
patients without causing discomfort and the patients 
were instructed to wear the EMA appliance every 
night for two months.
The iCAT CBCT machine (Imaging Sciences 
International, PA, USA) and 3dMD imaging system 
(3dMD, GA, USA) were used to scan each subject 
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twice, with two months’ interval between the initial 
(T1) and the final visit (T2). The scans were acquired 
with the EMA in place for the OSA group and 
without the EMA for the control group. The CBCT 
scans had a voxel size of 0.3 mm and were exposed 
for 8.9 seconds. A 12-inch receptor field was applied 
to include the cervical vertebrae 4 (CV4) to the 
cranial base and the soft-tissue contours of the face. 
The CBCT images were uploaded into Dolphin 3D 
software (Dolphin Imaging & Management System, 
CA, USA) and digital 3D models of the airway 
and the surrounding craniofacial structures were 
reconstructed. The airway volume, MCA, and selected 
craniofacial parameters were evaluated using the same 
software. The 3D volumetric images were oriented 
for each individual so that the midsagittal plane was 
aligned to the skeletal midline (N-ANS-Ba) of the 
face, the axial plane was aligned to the level of FH 
plane (Po-Or), and the coronal plane was aligned to 
the level of the furcation point of the right maxillary 
first molar. The boundaries of each airway segment 
(nasal cavity, nasopharynx, oropharynx, hypopharynx 
and the maxillary sinuses) and the MCA, as well as the 
definition of the craniofacial parameters used in the 
study, are described in Tables I and II, and Figures 2–6. 
Statistical analysis
To assess the intra-rater reliability, landmarks were 
identified and the airway volume as well as the 
selected parameters were measured twice by the 
same investigator following an interval of two weeks 
on 10 selected CBCT scans. Intra-class correlation 
coefficients and Bland-Altman plots were used to 
determine reliability. The CBCT volumetric and 
linear measurements of the airway as well as the size 
of the MCA were summarised (mean ± standard 
deviation) by grouping. The differences in the T1 
and T2 measurements were compared using repeated 
measures analysis of variance (rmANOVA) to analyse 
the effects of the appliance in each group. The 
statistical significance level was set at p ≤ 0.05.
Results
The ICC values showed high intra-rater reliability 
(> 0.90) for all parameters. Statistically significant 
decreases were detected between T2 and T1 in the 
Epworth score for all test groups but groups 3 and 4 
showed a statistically significant decrease in AHI and 
RDI (Table III).
Figure 1. EMA Appliance.
Figure 2. Airway segments; (A) nasal cavity; (B) nasopharynx; 
(C) oropharynx.
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Figure 3. (A) Total airway volume and (B) cross sectional view of the most constricted area.
Figure 4. Soft palate surface area. Figure 5. Soft tissue thicknesses and 
sagittal depth of the airway at the levels 
of nasopharynx and oropahyrnx.
Figure 6. Cervical vertebrae angulation.
Anatomical area Anterior boundary Posterior boundary Superior boundary Inferior boundary 
Nasal cavity (mm3) anterior nasal spine (ANS) – 
the tip of the nasal bone  
– Nasion (N) 
Sella point (S) –  
posterior nasal spine 
(PNS) 
Nasion (N) – Sella 
point (S) 
anterior nasal spine 
(ANS) – posterior  
nasal spine (PNS) 
Nasopharynx (mm3) S – PNS S – tip of the odontoid 
process 
PNS – tip of the 
odontoid process 
Oropharynx (mm3) PNS  – hyoid bone (hy) tip of the odontoid 
process – C4ps 
PNS – tip of the 
odontoid process 
hy  – C4ps 
Total airway (mm3) S – PNS – hyoid bone (hy) S – tip of the odontoid 
process – C4ps
hy  – C4ps
MCA (mm2) The most constricted area (MCA) will be detected automatically by the software along the airway 
passage
Soft Palate area 
(mm2)
Confined by the soft palate that starts and ends at PNS through the uvula tip
Table I.  Definitions of anatomical areas used in the study.
Following the use of the EMA appliance, statistically 
significant increases were found in the volume of the 
nasopharynx, oropharynx, and total airway in all OSA 
groups. The MCA of the airway increased significantly 
in groups 2 and 3 and non-significantly in group 4. 
The soft palate area decreased significantly in the OSA 
groups (Table IV).
All craniofacial parameters except CVT-FH changed 
significantly for all OSA subjects. The sagittal depth 
of the airway significantly increased in groups 2 
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Table II.  The 3D measurements of the craniofacial complex used in the study.
Parameters Description
Ba – ppw (mm) Thickness of the soft tissue of the posterior wall of the airway at the nasopharynx level from Basion.
PNS – ppw (mm) Sagittal depth of the airway at the nasopharynx level.
CV2ia – ppw (mm) Thickness of the soft tissue of the posterior wall of the airway at the oropharynx level.
CV2ia - AW (mm) Sagittal depth of the airway at the oropharynx level.
CVT – FH (°)
The inclination of the cervical column represented as the angle between the cervical vertebrae tangent 
(CVT), the line connects the most posterior and superior point on CV2 and the most posterior and 
superior point on CV4, and the FH Plane.
Overjet (mm) The horizontal distance between the incisal edges of the maxillary and mandibular central incisors as projected on the facial plane (nasion – pogonion).




Mean SD Mean SD Mean SD
G1
BMI (Kg/m2) 24.9 3.1 25.1 2.9 0.2 0.4 0.32
Neck size (inch) 15.6 0.8 15.6 0.9 0 0.4 0.46
AHI 1.5 1 1.6 1 0.2 0.6 0.94
RDI 5.8 2.4 7.7 2.5 1.9 2.1 0.57
Epworth score 3.3 1.8 2.6 2.2 -0.6 1 0.00*
Snoring (%) 5.9 8.6 7.8 12.1 1.9 7.7 0.69
G2
BMI (Kg/m2) 30.4 4.6 29.9 4.8 -0.5 0.7 0.29
Neck size (inch) 17.0 1.1 17.2 1.5 0.2 0.8 0.49
AHI 7.7 2.6 5.8 2.3 -1.9 4.1 0.41
RDI 18.2 5.3 14.2 8.2 -4.0 7.0 0.22
Epworth score 8.8 3.1 5.4 2.8 -3.3 2.5 0.00*
Snoring (%) 23.1 10.9 23.2 19.8 0.0 14.8 0.69
G3
BMI (Kg/m2) 31.6 6.7 31.6 6.4 0.0 1.0 0.29
Neck size (inch) 17.7 1.6 17.5 1.5 -0.1 0.4 0.49
AHI 19.8 4.6 9.3 3.9 -10.5 6.1 0.00*
RDI 35.9 10.1 18.5 6.9 -17.4 12.9 0.00*
Epworth score 8.9 5.9 6.3 5.2 -2.7 3.3 0.00*
Snoring (%) 32.4 12.2 29.3 17.0 -3.1 10.6 0.64
G4
BMI (Kg/m2) 35.8 6.9 35.8 7.0 -0.1 0.3 0.29
Neck size (inch) 18.1 1.1 18.3 1.9 0.3 1.2 0.49
AHI 52.3 15.3 32.8 26.4 -19.6 14.2 0.00*
RDI 62.0 14.5 43.4 27.7 -18.6 16.6 0.00*
Epworth score 11.8 6.4 8.2 4.0 -3.6 4.5 0.00*
Snoring (%) 40.6 11.1 39.0 12.2 -1.6 9.8 0.64
Table III.  Comparison of sleep test parameters between T1 and T2.
*Statistically significant at p ≤ 0.05, BMI: body mass index, AHI: apnoea-hypopnea index, RDI: respiratory disturbance index  
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and 3 at the level of the nasopharynx, and increased 
significantly in all OSA groups at the level of the 
oropharynx. The soft tissue thickness of the airway 
decreased significantly in groups 2 and 3 at the level 
of the nasopharynx, and decreased significantly in all 
OSA groups at the level of the oropharynx. Overbite 
and overjet decreased significantly in all OSA groups 
(Table V).
Discussion
OSA is a common disorder associated with serious 
medical consequences and a number of related risk 
factors. Oral appliances are increasingly considered 
as viable treatment options for mandibular deficiency 
and OSA. The anterior displacement of the mandi-
ble and forward positioning of the tongue has been 
recommended for the relief of upper airway obstruc-
tion.19-21 OSA patients who cannot tolerate a CPAP 
machine are usually offered alternative treatment op-
tions that may include upper airway surgery in the 
form of maxillomandibular advancement, uvulopha-
ryngo-palatoplasty, laser-assisted uvulopalatoplasty, 
and radiofrequency ablation.22 The temperature- 
controlled radiofrequency tissue volume reduction for 
the soft palate and base of the tongue is also consid-
ered a treatment option for mild to moderate OSA.23 
In addition to the low percentage rate of success, the 
literature has also reported a number of side effects 
and adverse events following surgery to the upper 
airway, such as difficulty swallowing, nasal regurgita-
tion, taste disturbances, voice changes, post-operative 




Mean SD Mean SD Mean SD
G1
Nasal cavity (mm3) 27657.8 3989 27652.8 3979.6 -5 17.6 0.98
Nasopharynx (mm3) 11296.7 3194.4 11296.3 3192.1 -0.5 3.4 0.99
Oropharynx (mm3) 31797.3 11023 30874.3 10031 -923 3060.2 0.42
Total airway (mm3) 43094 13651.4 42170.6 12367.3 -923.4 3063.2 0.44
MCA (mm2) 328.3 120.3 322.3 113.6 -6 19.6 0.65
S Palate area (mm2) 321.4 69.7 327.3 70.5 5.8 19.5 0.57
G2
Nasal cavity (mm3) 21085.0 4150.0 20828.0 4097.0 -257 510 0.35
Nasopharynx (mm3) 8621.0 2723.0 9488.0 2276.0 868 917 0.00*
Oropharynx (mm3) 17030.0 5264.0 22464.0 5833.0 5434.0 4656.0 0.00*
Total airway (mm3) 25651.0 6855.0 31952.0 6585.0 6301.0 4917.0 0.00*
MCA (mm2) 154.8 73.5 209.7 86.6 55.0 71.0 0.00*
S Palate area (mm2) 348.3 107.3 306.4 83.1 -42.0 53.0 0.00*
G3
Nasal cavity (mm3) 21958.0 5503.0 21909.0 5447.0 -49.0 102.0 0.35
Nasopharynx (mm3) 8519.0 2787.0 9397.0 3325.0 878.0 947.0 0.00*
Oropharynx (mm3) 17349.0 8022.0 20844.0 9454.0 3495.0 2403.0 0.00*
Total airway (mm3) 25868.0 10458.0 30241.0 12437.0 4373.0 3234.0 0.00*
MCA (mm2) 151.1 80.3 188.0 114.4 37.0 93.0 0.00*
S Palate area (mm2) 348.8 101.7 318.7 84.4 -30.0 28.0 0.00*
G4
Nasal cavity (mm3) 21909.0 4510.0 21646.0 4423.0 -263.0 528.0 0.35
Nasopharynx (mm3) 5783.0 3645.0 6332.0 3922.0 549.0 662.0 0.01*
Oropharynx (mm3) 10435.0 5269.0 13972.0 3375.0 3537.0 5276.0 0.00*
Total airway (mm3) 16187.0 7509.0 20556.0 4803.0 4368.0 5873.0 0.01*
MCA (mm2) 84.4 32.2 92.2 29.8 8.0 11.0 0.52
S Palate area (mm2) 428.9 67.7 410.2 71.6 -19.0 19.0 0.05*
Table IV.  Comparison of airway volumes and soft palate area between T1 and T2.
*Statistically significant at p ≤ 0.05  
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Portable home systems to monitor OSA are cur-
rently used to minimise patient medical costs, time 
off work, and the obvious problems of uncomfort-
ably sleeping in a strange environment. The ARES™ 
system (Watermark Medical, FL, USA), an approved 
Food and Drug Administration (FDA) device, is a 
wireless recorder worn on the forehead with cannu-
las inserted into the nasal apertures. The recorder is 
equipped with reflectance pulse oximetry to measure 
blood oxygen saturation and pulse rate, a pressure 
transducer to the nasal cannula to measure airflow, 
calibrated acoustic microphone and two dual-access 
accelerometers to measure snoring levels, head move-
ment and position. Frontal lobe derivations record en-
cephalogram data and an internal algorithm estimates 
sleep time based on non-movement and regularity of 
nasal flow and/or snoring. The recorder can hold as 
many as three nights of data.27 The concordance with 
laboratory polysomnography has been found to be 
high (ICC = 0.8) and the sensitivity of the in-home 
ARES™ for Sleep Disordered Breathing is reported 
as 85% and the specificity as 91%.28 
The EMA appliance used in the present study 




Mean SD Mean SD Mean SD
G1
Ba-ppw (mm) 20.3 2.8 20.3 2.8 0 0.1 98
PNS-ppw (mm) 31.9 2.7 31 4.6 -0.9 3 0.15
CV2ia-ppw (mm) 4.6 1 4.6 1 0 0.2 0.34
CV2ia-AW (mm) 14.4 4.1 14.4 4.1 0 0.1 0.92
CVT-FH (°) 84.8 4.8 84.8 3.8 0 0.1 0.1
OJ (mm) 2.7 1.5 2.7 1.5 0 0.1 0.99
OB (mm) 3.6 1.8 3.6 1.8 0 0.1 98
G2
Ba-ppw (mm) 20.2 2.8 19 2 -1.2 1.7 0.00*
PNS-ppw (mm) 30.8 5.7 32.4 4.8 1.6 2.3 0.01*
CV2ia-ppw (mm) 4.5 1.2 4.1 0.9 -0.4 0.5 0.00*
CV2ia-AW (mm) 13.4 4.3 14.8 3.3 1.4 2.1 0.00*
CVT-FH (°) 80.2 5 81.2 4.5 1.1 2 0.06
OJ (mm) 3.3 1.6 -0.1 2.9 -3.5 3 0.00*
OB (mm) 4.2 2 -6.2 5.1 -10.4 4.8 0.00*
G3
Ba-ppw (mm) 20.8 3.1 19.4 2.9 -1.5 1.6 0.00*
PNS-ppw (mm) 27.6 3.8 28.8 3.5 1.2 1 0.04*
CV2ia-ppw (mm) 4.7 1.2 4 1 -0.7 0.9 0.00*
CV2ia-AW (mm) 9.8 2.5 11.9 2.7 2.1 1.5 0.00*
CVT-FH (°) 84 3.9 84.7 4.2 0.8 2 0.06
OJ (mm) 3.7 1 2.5 2.1 -1.2 1.7 0.03*
OB (mm) 3.7 0.8 -6.9 1.8 -10.6 1.5 0.00*
G4
Ba-ppw (mm) 20.9 2.1 20.3 1.8 -0.6 0.5 0.08
PNS-ppw (mm) 24.9 2.5 25.6 2.4 0.7 1.2 0.23
CV2ia-ppw (mm) 5.6 1 5.1 0.8 -0.5 0.9 0.00*
CV2ia-AW (mm) 11.6 2.8 12.5 3.1 1 1.3 0.03*
CVT-FH (°) 81.3 5.4 81.2 5.7 -0.1 1.4 0.06
OJ (mm) 3.9 1.3 2.6 1.4 -1.3 1.2 0.02*
OB (mm) 3.8 1.3 -8 2.4 -11.8 1.8 0.00*
Table V.  Comparison of craniofacial parameters between T1 and T2.
*Statistically significant at p ≤ 0.05
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attached to upper and lower custom-made stents. 
These pulled the mandible in a forward position and 
made the appliance less bulky and more comfortable 
for patients compared with appliances which utilise 
threaded screws or telescopic arms. Variable lengths 
of elastic strap allowed control over the desired 
amount of advancement. The achieved mandibular 
advancement was standardised by providing same-
length elastic strap (21 mm) to hold the mandible 4 
mm in a forward position while vertical opening was 
adjusted by using same-size bite planes. 
The new generations of the CBCT scanners and 
the advances in 3D imaging software enable the 
accurate volumetric evaluation of the airway and its 
surrounding tissues with low radiation exposure. In 
addition, the scans allow accurate visualisation of 
the airway and more precise analysis.29-32 Calculation 
of MCA and cross-sectional areas of the airway in 
three planes of space is facilitated. The axial plane, 
which is not visualised on a lateral cephalogram, is 
the most physiologically relevant plane because it is 
perpendicular to the airflow. It has been previously 
reported that the accuracy and reliability of digital 
measurements of airway volume on CBCTs compared 
with the volume measured manually of an airway 
model was excellent.30-32 CBCT was therefore chosen 
as the method of evaluation in the current research. 
However, the use of CBCT should also be considered 
a limitation as patients were scanned awake and in 
an upright position, which may not represent the 
situation and position during sleep.
The ESS is a standardised self-rating system used 
to assess subjective sleepiness by using 0-3 scale in 
which (0) indicates ‘would never doze’ and (1, 2 and 
3) indicate that there is a slight, moderate, and high 
chance of dozing throughout the day or during critical 
activities.33 The ESS, although subjective, is considered 
a reliable method for measuring persistent daytime 
sleepiness in adults.34 In the current study, Epworth 
scale showed a statistically significant decrease 
following the use of EMA appliance and inducing an 
obvious improvement in OSA symptoms. The mean 
score of the Epworth scale decreased significantly for 
the OSA groups.
As shown in Table III, the EMA was effective in 
decreasing the number of apnoea and hypopnoea 
episodes per hour of sleep. The level of reduction in 
AHI (an objective score) was statistically significant in 
groups 3 and 4, which reinforced the changes seen in 
the ESS scores. This indicated that the use of the EMA 
is expected to reduce the severity of the condition 
by one category for more severe cases by reducing 
severe OSA to moderate and moderate OSA to mild. 
Although there was an improvement in snoring as 
reported by the OSA group, the improvement was not 
statistically significant.
Ferguson et al.16 reported that the efficiency of oral 
appliances might be affected by several factors related 
to the severity of OSA, the extent of appliance 
mandibular advancement, the position of individuals 
during sleep, and the body mass index (BMI). In 
agreement with these findings, the current data 
demonstrated that the number of apnoea-hypopnoea 
events per hour during sleep decreased as the severity of 
OSA increased with an average amount of mandibular 
advancement and mandibular opening for the OSA 
groups. Although BMI and neck size, in this study, 
showed an inconsiderable increase associated with 
the increase in OSA severity, the increase in BMI and 
neck size were not significant for all groups. Solow et 
al.35 reported that airway obstruction at the level of 
the nasopharynx was affected by the cranio-cervical 
angulation. The present data demonstrated that 
the inclination of the cervical column showed non-
significant changes in all groups, which negated the 
effect of head posture changes on the airway size.
The results of the present study demonstrated 
statistically significant decreases in the soft tissue 
thickness of the posterior wall of the airway at the 
levels of the nasopharynx and oropharynx with a 
concomitant significant increase in the airway lumen 
at those levels. The results might be explained by 
the function of the appliance, which causes forward 
and downward displacement of the mandible and 
an associated downward and forward positioning of 
the tongue that consequently leads to an increase in 
airway size. The appliance also causes stretching of the 
soft tissue, which could possibly explain the significant 
decrease in soft palate size. 
In conclusion, the results of the current study con-
firmed the effectiveness of EMA in increasing airway 
volume, widening MCA of the airway and improving 
snoring and sleep quality, although the snoring im-
provement was statistically not significant. Orthodon-
tists have the opportunity to recognise abnormal air-
way anatomy and refer patients for OSA evaluation by 
a sleep medicine physician. A collaborative approach 
with physicians might provide effective non-invasive 
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treatment that objectively produces sleeping improve-
ment which patients subjectively recognise.
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